{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T22:12:26Z","timestamp":1774563146456,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s00105-016-3853-8","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T13:02:36Z","timestamp":1469797356000},"page":"718-723","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Terbinafin","Terbinafine"],"prefix":"10.1007","volume":"67","author":[{"given":"A.","family":"D\u00fcrrbeck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Nenoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,29]]},"reference":[{"key":"3853_CR1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0009-9236(99)70065-2","volume":"65","author":"SM Abdel-Rahman","year":"1999","unstructured":"Abdel-Rahman SM, Gotschall R, Kauffman RE et al (1999) Investigation of terbinafine as a CYP2D6 inhibitor in vivo. Clin Pharmacol Ther 65:465\u2013472","journal-title":"Clin Pharmacol Ther"},{"key":"3853_CR2","unstructured":"http:\/\/www.fda.gov\/drugs\/developmentapprovalprocess\/developmentresources\/druginteractionslabeling\/ucm093664.htm#classInhibit . Zugegriffen: 20. Mai 2016"},{"key":"3853_CR3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/sj.clpt.6100311","volume":"83","author":"VV Hynninen","year":"2008","unstructured":"Hynninen VV, Olkkola KT, Bertilson L et\u00a0al (2008) Effect of terbinafine and voriconazole on the pharmacokinetics of the antidepressant venlafaxine. Clin Pharmacol Ther 83:342\u2013348","journal-title":"Clin Pharmacol Ther"},{"key":"3853_CR4","unstructured":"Lamisil\u00ae 250\u202fmg Tabletten. Fachinformation, Stand September 2013. http:\/\/www.fachinfo.de\/suche\/fi\/004734 . Zugegriffen: 14. Juni 2016"},{"key":"3853_CR5","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1177\/009127002762491299","volume":"42","author":"S Madani","year":"2002","unstructured":"Madani S, Barilla D, Cramer J et\u00a0al (2002) Effect of terbinafine on the pharmacokinetics and pharmacodynamics of desipramine in healthy volunteers identified as cytochrome P450 2D6 (CYP2D6) extensive metabolizers. J\u00a0Clin Pharmacol 42:1211\u20131218","journal-title":"J Clin Pharmacol"},{"key":"3853_CR6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1055\/s-0038-1629365","volume":"13","author":"P Nenoff","year":"2013","unstructured":"Nenoff P, Kr\u00fcger C, Schulze I, Lietzberg B, Friedlein H, Ginter-Hanselmayer G (2013) Dermatophyten-Infektionen der Haut, Haare und N\u00e4gel bei Kindern \u2013 ein Update. Teil\u00a02. Diagnostik Ther Kinder- Jugendmed 13:438\u2013444","journal-title":"Diagnostik Ther Kinder- Jugendmed"},{"key":"3853_CR7","first-page":"387","volume":"13","author":"P Nenoff","year":"2015","unstructured":"Nenoff P, Kr\u00fcger C, Paasch U, Ginter-Hanselmayer G (2015) Mykologie \u2013 ein Update. Teil\u00a03: Dermatomykosen: topische und systemische Behandlung. J Dtsch Dermatol Ges 13:387\u2013413","journal-title":"J Dtsch Dermatol Ges"},{"key":"3853_CR8","unstructured":"Nolvadex\u00ae 20\u202fmg Filmtabletten. Fachinformation, Stand August 2015. http:\/\/www.fachinfo.de\/suche\/fi\/001493 . Zugegriffen: 23. Juni 2016"},{"key":"3853_CR9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000018488","volume":"201","author":"N Shear","year":"2000","unstructured":"Shear N, Drake L, Gupta AK et\u00a0al (2000) The implications and management of drug interactions with itraconazole, fluconazole and terbinafine. Dermatology 201:196\u2013203","journal-title":"Dermatology"},{"key":"3853_CR10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s00105-012-2448-2","volume":"63","author":"HJ Tietz","year":"2012","unstructured":"Tietz HJ, Nenoff P (2012) Die Onychomykose \u2013 ein Kronjuwel der Dermatologie. Hautarzt 63:842\u2013847","journal-title":"Hautarzt"},{"key":"3853_CR11","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1345\/aph.1C083","volume":"36","author":"PH Kuy Van Der","year":"2002","unstructured":"Van Der Kuy PH, Van Den Heuvel HA, Kempen RW et\u00a0al (2002) Pharmacokinetic interaction between nortriptyline and terbinafine. Ann Pharmacother 36:1712\u20131714","journal-title":"Ann Pharmacother"},{"key":"3853_CR12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003088-200038020-00002","volume":"38","author":"K Venkatakrishnan","year":"2000","unstructured":"Venkatakrishnan K, von Moltke LL, Greenblatt DJ (2000) Effects of the antifungal agents on oxidative drug metabolism: Clinical relevance. Clin Pharmacokinet 38:111\u2013180","journal-title":"Clin Pharmacokinet"},{"key":"3853_CR13","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0090-9556(24)15022-2","volume":"27","author":"AE Vickers","year":"1999","unstructured":"Vickers AE, Sinclair JR, Zollinger M et al (1999) Multiple cytochrome P\u2011450\u202fs involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions. Drug Metab Dispos 27:1029\u20131038","journal-title":"Drug Metab Dispos"},{"key":"3853_CR14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00228-006-0217-9","volume":"63","author":"N Yasui-Furukori","year":"2007","unstructured":"Yasui-Furukori N, Saito M, Inoue Y et al (2007) Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects. Eur J Clin Pharmacol 63:51\u201356","journal-title":"Eur J Clin Pharmacol"},{"key":"3853_CR15","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1007\/s00101-013-2233-3","volume":"62","author":"EM Zeidler","year":"2013","unstructured":"Zeidler EM, Goetz AE, Z\u00f6llner C (2013) Pharmakogenetik. Anaesthesist 62:874\u2013886. doi: 10.1007\/s00101-013-2233-3","journal-title":"Anaesthesist"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3853-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-016-3853-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3853-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T09:18:09Z","timestamp":1749028689000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-016-3853-8"}},"subtitle":["Relevante Arzneimittelinteraktionen und deren Management","Relevant drug interactions and their management"],"short-title":[],"issued":{"date-parts":[[2016,7,29]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["3853"],"URL":"https:\/\/doi.org\/10.1007\/s00105-016-3853-8","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,29]]}}}